← Leaderboards
Philip T Loverde
State University Of New York At Buffalo
$11,147,584
Attributed
$14,518,710
Total exposure
13
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$14,518,710 · 13
By mechanism
R01$10,854,547 · 5
U01$1,570,925 · 1
R56$810,158 · 1
D43$726,450 · 1
R21$453,240 · 1
R03$80,640 · 1
Top collaborators
- Tim J Anderson7 shared
- Peter John Hart3 shared
- Sevan Najm Alwan1 shared
- Michael Darin Cameron1 shared
- Stanton Furst Mchardy1 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Antonia Courtney Perez$120,052
Others in their field
Top investigators on “Schistosoma Mansoni”
- Eric S Loker · University Of New Mexico$10,183,441
- Tim J Anderson · Texas Biomedical Research Institute$9,487,078
- Edward J. Pearce · Cornell University Ithaca$8,948,635
- James J Collins · Ut Southwestern Medical Center$8,321,594
- Miguel J. Stadecker · Tufts University Boston$6,702,512
- Jonathan L Vennerstrom · University Of Nebraska Medical Center$5,960,375
Research focus
Schistosoma MansoniSchistosomiasisSchistosomaPraziquantelGenesSchistosome ParasiteParasitesHost Organism InteractionBaseParasite ResistanceResistanceMolecularProgramsResponsePhenotypeInterestGenetic MarkersPharmaceutical PreparationsDrug Effect DisorderEvolutionMapsClinical ResearchEnzymesSafety
Grant awards (42)
Preclinical Testing of Potential Next-generation Antischistosomal Compounds$810,158
R56 · FY2024 · AI · contact PI
Genetic Basis of Praziquantel Resistance$684,991
R01 · FY2020 · AI
Genetic Basis of Praziquantel Resistance$713,041
R01 · FY2019 · AI
Structure-guided redesign of an antischistosomal drug$515,587
R01 · FY2019 · AI · contact PI
Molecular Helminthology: An Integrated Approach$6,500
R13 · FY2019 · AI · contact PI
Genetic Basis of Praziquantel Resistance$684,991
R01 · FY2018 · AI
Structure-guided redesign of an antischistosomal drug$515,585
R01 · FY2018 · AI · contact PI
Genetic Basis of Praziquantel Resistance$713,041
R01 · FY2017 · AI
Structure-guided redesign of an antischistosomal drug$515,585
R01 · FY2017 · AI · contact PI
Genetic Basis of Praziquantel Resistance$706,741
R01 · FY2016 · AI
Structure-guided redesign of an antischistosomal drug$515,587
R01 · FY2016 · AI · contact PI
Structure-guided redesign of an antischistosomal drug$539,799
R01 · FY2015 · AI · contact PI
Efficient Linkage Mapping Methods for Schistosoma mansoni$188,427
R21 · FY2013 · AI
Efficient Linkage Mapping Methods for Schistosoma mansoni$264,813
R21 · FY2012 · AI
Toward a Molecularly-Defined Vaccine for Schistosomiasis$344,521
R01 · FY2009 · AI · contact PI
Toward a Molecularly-Defined Vaccine for Schistosomiasis$344,854
R01 · FY2008 · AI · contact PI
Toward a Molecularly-Defined Vaccine for Schistosomiasis$349,912
R01 · FY2007 · AI · contact PI
Training to Enhance Schistosomiasis Research in Brazil$133,950
D43 · FY2007 · TW · contact PI
Toward a Molecularly-Defined Vaccine for Schistosomiasis$349,033
R01 · FY2006 · AI · contact PI
TRAINING IN EMERGING AND RE-EMERGING DISEASES IN BRAZIL$142,500
D43 · FY2006 · TW · contact PI
Toward a Molecularly-Defined Vaccine for Schistosomiasis$359,739
R01 · FY2005 · AI
TRAINING IN EMERGING AND RE-EMERGING DISEASES IN BRAZIL$150,000
D43 · FY2005 · TW
Conference--Molecular Helminthology, Integrated Approach$13,750
R13 · FY2005 · AI
SIGNAL TRANSDUCTION IN SCHISTOSOMES$387,952
R01 · FY2004 · AI
HOST GENETIC CORRELATES IN SCHISTOSOMIASIS$319,402
U01 · FY2004 · AI
TRAINING IN EMERGING AND RE-EMERGING DISEASES IN BRAZIL$150,000
D43 · FY2004 · TW
Immune evasion by the human blood fluke Schistosoma man*$40,320
R03 · FY2004 · TW
SIGNAL TRANSDUCTION IN SCHISTOSOMES$376,652
R01 · FY2003 · AI
HOST GENETIC CORRELATES IN SCHISTOSOMIASIS$305,023
U01 · FY2003 · AI
TRAINING IN EMERGING AND RE-EMERGING DISEASES IN BRAZIL$150,000
D43 · FY2003 · TW
Immune evasion by the human blood fluke Schistosoma man*$40,320
R03 · FY2003 · TW
SIGNAL TRANSDUCTION IN SCHISTOSOMES$365,682
R01 · FY2002 · AI
TOWARD A MOLECULARLY DEFINED VACCINE FOR SCHISTOSOMIASIS$318,016
R01 · FY2002 · AI
HOST GENETIC CORRELATES IN SCHISTOSOMIASIS$273,415
U01 · FY2002 · AI
HOST GENETIC CORRELATES IN SCHISTOSOMIASIS$364,482
U01 · FY2001 · AI
SIGNAL TRANSDUCTION IN SCHISTOSOMES$355,030
R01 · FY2001 · AI
TOWARD A MOLECULARLY DEFINED VACCINE FOR SCHISTOSOMIASIS$308,753
R01 · FY2001 · AI
IDENTIFICATION OF NATURALLY PROCESSED SMANSONI PEPTIDES$245,005
R01 · FY2001 · AI
CONFERENCE ON MOLECULAR HELMINTHOLOGY$2,500
R13 · FY2001 · AI
SIGNAL TRANSDUCTION IN SCHISTOSOMES$344,689
R01 · FY2000 · AI
HOST GENETIC CORRELATES IN SCHISTOSOMIASIS$308,603
U01 · FY2000 · AI
TOWARD A MOLECULARLY DEFINED VACCINE FOR SCHISTOSOMIASIS$299,761
R01 · FY2000 · AI